131 222

Cited 10 times in

Pulmonary hypertension associated with use of phentermine

DC FieldValueLanguage
dc.contributor.author유희태-
dc.contributor.author장지용-
dc.contributor.author장혁재-
dc.contributor.author정보영-
dc.contributor.author조성수-
dc.contributor.author방우대-
dc.contributor.author오창명-
dc.date.accessioned2015-04-23T17:49:31Z-
dc.date.available2015-04-23T17:49:31Z-
dc.date.issued2010-
dc.identifier.issn0513-5796-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/103205-
dc.description.abstractWeight-control drugs (known as anorexigens) such as fenfluramine have been linked with pulmonary hypertension in previous reports. In our case, a 29 year old woman was admitted for shortness of breath and was diagnosed with pulmonary hypertension. Three months ago, she had been taking phentermine for five weeks. Other factors that might have contributed to the development of pulmonary hypertension were excluded. With treatment, her symptoms improved. This is the first case that can suggest a possible connection between phenermine single medication with pulmonary hypertension. Phentermine has been considered a relatively safe drug to treat obesity, and further investigation is needed to decide the safety and dosage of phentermine.-
dc.description.statementOfResponsibilityopen-
dc.format.extent971~973-
dc.relation.isPartOfYONSEI MEDICAL JOURNAL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdult-
dc.subject.MESHAntihypertensive Agents/therapeutic use-
dc.subject.MESHElectrocardiography/methods-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHHypertension, Pulmonary/drug therapy*-
dc.subject.MESHHypertension, Pulmonary/etiology*-
dc.subject.MESHModels, Chemical-
dc.subject.MESHObesity/drug therapy-
dc.subject.MESHPhentermine/adverse effects*-
dc.subject.MESHPhentermine/therapeutic use*-
dc.subject.MESHRadiography, Thoracic/methods-
dc.subject.MESHSafety-
dc.subject.MESHSulfonamides/therapeutic use-
dc.titlePulmonary hypertension associated with use of phentermine-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorWoo-Dae Bang-
dc.contributor.googleauthorJi-Ye Kim-
dc.contributor.googleauthorHee-Tae Yu-
dc.contributor.googleauthorSung-Soo Cho-
dc.contributor.googleauthorJi-Yong Jang-
dc.contributor.googleauthorChang-Myung Oh-
dc.contributor.googleauthorBoyoung Joung-
dc.contributor.googleauthorHyuk-Jae Chang-
dc.identifier.doi10.3349/ymj.2010.51.6.971-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA02535-
dc.contributor.localIdA03490-
dc.contributor.localIdA03609-
dc.contributor.localIdA03833-
dc.contributor.localIdA01787-
dc.contributor.localIdA02405-
dc.contributor.localIdA03476-
dc.relation.journalcodeJ02813-
dc.identifier.eissn1976-2437-
dc.identifier.pmid20879069-
dc.subject.keywordPhentermine-
dc.subject.keywordpulmonary hypertension-
dc.contributor.alternativeNameYu, Hee Tae-
dc.contributor.alternativeNameJang, Ji Yong-
dc.contributor.alternativeNameChang, Hyuck Jae-
dc.contributor.alternativeNameJoung, Bo Young-
dc.contributor.alternativeNameCho, Sung Soo-
dc.contributor.alternativeNameBang, Woo Dae-
dc.contributor.alternativeNameOh, Chang Myung-
dc.contributor.affiliatedAuthorYu, Hee Tae-
dc.contributor.affiliatedAuthorChang, Hyuck Jae-
dc.contributor.affiliatedAuthorJoung, Bo Young-
dc.contributor.affiliatedAuthorCho, Sung Soo-
dc.contributor.affiliatedAuthorBang, Woo Dae-
dc.contributor.affiliatedAuthorOh, Chang Myung-
dc.contributor.affiliatedAuthorJang Ji Yong-
dc.citation.volume51-
dc.citation.number6-
dc.citation.startPage971-
dc.citation.endPage973-
dc.identifier.bibliographicCitationYONSEI MEDICAL JOURNAL, Vol.51(6) : 971-973, 2010-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.